The South & Central America noninvasive fat reduction market was valued at US$ 86.41 million in 2023 and is projected to reach US$ 224.54 million by 2031; it is estimated to register a CAGR of 12.7% from 2023 to 2031.
The table below highlights the noninvasive fat reduction-centric products launched by companies operating in the market.
|
Date |
Company Name |
Product Name |
Product Description |
|
Jan-21 |
AbbVie, Inc. |
CoolSculpting Elite |
CoolSculpting Elite is a clinically proven technology to target, freeze, and eliminate treated fat cells. The product is FDA-cleared to treat visible fat bulges in nine areas of the body, including the thigh, abdomen, and flank, as well as bra fat, back fat, underneath the buttocks, upper arm, and the submental and submandibular areas. |
|
Apr-22 |
VLCC |
VLCC Lipo-1060 |
VLCC Lipo-1060 treatment uses the latest laser appliances of specific wavelengths that enable noninvasive body contouring and slimming without pain and ensure that only fat cells are eliminated with skin protection. The technology used in the treatment has been clinically proven to consistently reduce the fat contour in the abdomen and other areas of the body, with an excellent safety profile in all skin types. |
|
Mar-23 |
truBody Brand |
- |
truBody Brand is an award-winning treatment pair intended for a customized, convenient, and complete approach to fat reduction and muscle toning with only a 15-minute treatment duration. The truSculpt (formerly truSculpt iD) for fat reduction is a fast and effective combination approach, allowing practitioners and patients to provide optimal results for reducing fat and toning muscle. |
Additionally, Medicis’s Liposonix is a new treatment technique that uses a high-intensity focused ultrasound device to eliminate fat beneath the skin. The company reportedly received FDA approval for noninvasive waist circumference reduction. Such innovative product approvals and launches are expected to enhance the market growth of noninvasive fat reduction during the forecast period.
South & Central America region included key countries such as Brazil, Argentina, and Rest of South & Central America region. In South & Central America region, Brazil accounts major share for the noninvasive fat reduction devices. Additionally, Brazil will account highest CAGR of 13.9% for the forecast period 2023-2031. Brazil ranks 2nd after the US in aesthetic procedures and also considered as a profitable market according to the International Society of Aesthetic Plastic Surgery (ISAPS) report.
The South & Central America noninvasive fat reduction market is categorized into technology, end user, and country.
Based on technology, the South & Central America noninvasive fat reduction market is categorized into cryolipolysis, laser lipolysis, ultrasound, and others. The cryolipolysis segment held the largest market share in 2023.
In terms of end user, the South & Central America noninvasive fat reduction market is segmented into hospitals, dermatology clinics & cosmetic clinics, and others. The dermatology clinics & cosmetic clinics segment held the largest market share in 2023.
By country, the South & Central America noninvasive fat reduction market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America noninvasive fat reduction market share in 2023.
Lumenis, Cynosure LLC, Alma Lasers Ltd, Fotona, Venus Concept Inc, and Candela Corporation. are some of the leading companies operating in the South & Central America noninvasive fat reduction market.
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ 86.41 Million |
| Market Size by 2031 | US$ 224.54 Million |
| CAGR (2023 - 2031) | 12.7% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Technology
|
| Regions and Countries Covered |
South and Central America
|
| Market leaders and key company profiles |
|
The South & Central America Noninvasive Fat Reduction Market is valued at US$ 86.41 Million in 2023, it is projected to reach US$ 224.54 Million by 2031.
As per our report South & Central America Noninvasive Fat Reduction Market, the market size is valued at US$ 86.41 Million in 2023, projecting it to reach US$ 224.54 Million by 2031. This translates to a CAGR of approximately 12.7% during the forecast period.
The South & Central America Noninvasive Fat Reduction Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the South & Central America Noninvasive Fat Reduction Market report:
The South & Central America Noninvasive Fat Reduction Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The South & Central America Noninvasive Fat Reduction Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the South & Central America Noninvasive Fat Reduction Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)